112 LuoC.TaoL
Choosing the Right Semaglutide Option Klinic offers a variety of FDA-approved semaglutide and GLP-1 choices to match your lifestyle and medical needs
VERKADA FOUNDERS: Benjamin Bercovitz, Filip Kaliszan (CEO), James Ren, Hans Robertson EQUITY RAISED: $59 million ESTIMATED 2018 REVENUE: $20 million LEAD INVESTORS: First Round, Meritech, Next47, Sequoia While many startups have tackled the smart home with varying degrees of success, Verkada has exploded in shy of two years on the market by offering big businesses, municipalities and schools a cloud-based system that combines hardware and software to detect movement and easily store and share surveillance streams
Despite FDA crackdown, unapproved GLP-1s still threaten the industry Legitimate compounders are threatened by false advertising of counterfeit GLP-1s, legal experts warn
But this generation of millennials myself included are embracing and embodying it more than ever, reshaping what it means to be a woman, and a mom, in the process